Table: Ono Pharm -6-MTH group results (IFRS)

ONO PHARMACEUTICAL

31/10/2022 03:00

Oct 31 (Reuters)- 
              Ono Pharmaceutical Co Ltd 
              CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified) 
                   6 months ended      6 months ended       Year to 
                  Sep 30, 2022        Sep 30, 2021     Mar 31, 2023 
                     LATEST             YEAR-AGO          COMPANY   
                     RESULTS             RESULT          FORECAST   
  Sales              216.70              174.08           440.00    
                   (+24.5 pct)         (+15.7 pct)      (+21.8 pct) 
  Operating           80.27               58.17           149.00    
                   (+38.0 pct)         (+11.0 pct)      (+44.4 pct) 
  Pretax              81.02               59.23           150.00    
                   (+36.8 pct)         (+10.4 pct)      (+42.8 pct) 
  Net                 62.34               46.29           114.00    
                   (+34.7 pct)         (+16.2 pct)      (+41.6 pct) 
  EPS Basic        127.67 yen           92.74 yen       233.47 yen  
  EPS Diluted      127.66 yen           92.73 yen                   
  Ann Div                               56.00 yen        66.00 yen  
  -Q2 Div           33.00 yen           28.00 yen                   
  -Q4 Div                               28.00 yen        33.00 yen  
 
  NOTE - Ono Pharmaceutical Co Ltd. 
  (Figures are reported based on international accounting rules (IFRS).) 
  If there is no Q1 or Q3 dividend, Q2 will in most cases correspond to the first-half 
  dividend and Q4 to the second-half dividend announced before a new corporate law in 
  2006 allowed companies to pay and report dividends on a quarterly basis.
  *Net - represents Net profit attributable to owners of the parent company. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4528.T